News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
Top Breaking News
Amgen (AMGN) Terminates All Rilotumumab Clinical Trials For Advanced Gastric Cancer     11/24/2014
Lundbeck Inc. (LUN.CO) CEO Ulf Wiinberg Resigns After Breach Of Company Rules     11/24/2014
Regeneus (RGS.AX) Streamlines Management Structure, Operations And Reduces Costs     11/24/2014
Sinopharm Group To Rake In $716 Million From Share Placement     11/24/2014
Drug Giant Merck & Co. (MRK) Buys Rights To NewLink Genetics Ebola Vaccine rVSV-EBOV     11/24/2014
Syngenta AG (SYT) Downsizes; Plans Cuts Affecting 1,800 Jobs     11/24/2014
BioMarin Pharmaceutical Inc. (BMRN) Acquires ProSensa Holding N.V. (RNA) For Up To $840M; Gaining Experimental Drisapersen     11/24/2014
Trimel Pharmaceuticals (TRL.TO), Endo International (ENDP) Ink NATESTO Deal For Up To $195M     11/24/2014
Bioniche Life Sciences Inc. (BNC) Rebrands As Telesta Therapeutics Inc.     11/24/2014
Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall Of Northstar Label Gabapentin Capsules, USP 300 Mg Due To Complaints Of Empty Capsules     11/24/2014
Medicina Pharmaceuticals Release: Officials Of Two Pharmaceuticals Arrested For Supplying Adulterated Medicines     11/24/2014
Juno Therapeutics T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation     11/24/2014
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome     11/24/2014
Bristol-Myers Squibb Company (BMY) And Five Prime Therapeutics, Inc. (FPRX) Announce Exclusive Clinical Collaboration To Evaluate The Combination Of Investigational Immunotherapies Opdivo (nivolumab) And FPA008 In Six Tumor Types     11/24/2014
Bayer AG (BAYZF) To Use IPO Funds To Cut Debt And Buy Consumer Drugs     11/24/2014

Featured Stories
Investors Expect Record Year for Biotech Venture Capital     11/24/2014
Catalyst Pharmaceuticals (CPRX) CEO Outlines Biotech's 5 Phases Of Risk     11/24/2014
Generic Drugs Are Getting More Expensive; Keeping Prices Down Isn't A Matter Of New Regulations, Brigham Young University Reveals     11/24/2014
Diet Advice: More Persuasive When It's Based On Your DNA, University of Toronto Research Says     11/24/2014
Running Really Can Keep You Young, Says University of Colorado, And Humboldt State University Study     11/24/2014
Nail Stem Cells Prove More Versatile Than Press Ons, University of Southern California Study     11/24/2014
Stanford University Biologists Explore Link Between Memory Deficit And Misfiring Circadian Clock     11/24/2014
Pain From Rejection And Physical Pain May Not Be So Similar After All, University of Colorado Study     11/24/2014
Brain-Dwelling Worm In UK Man's Head Sequenced, Wellcome Trust Sanger Institute Study     11/24/2014
Testosterone May Play Modest Role In Menopausal Women’s Sex Drive, University of Michigan Health System Study     11/24/2014
Ebola Vaccine Running Into Patent Cover In Canada?     11/21/2014
Genzyme Corporation (GENZ) Parent Running At ‘Full Speed,’ Chairman Says     11/21/2014
Pac-Man Instead of Patch: Using Video Games To Improve Lazy Eye, Depth Perception, Ohio State University Study     11/21/2014
Many People Who Drink A Lot Aren't Alcoholics: CDC     11/21/2014
So What About That Acrylamide In Your French Fries?     11/21/2014

More News
Ariad Pharmaceuticals, Inc. (ARIA) And Specialised Therapeutics Australia Announce Approval Of Iclusig (Ponatinib) In Australia     11/24/2014
Merck & Co. (MRK) Submits New Drug Application To The Japanese Pharmaceuticals And Medical Devices Agency For Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes     11/24/2014
IGI Laboratories, Inc. Announces ANDA Submission     11/24/2014
Perrigo Company (PRGO) Confirms First To File Patent Challenge For Generic Version Of Aveed (Testosterone Undecanoate) Injection     11/24/2014
Onxeo Announces Positive DSMB Recommendation For Its Phase 3 Trial With Livatag® In Primary Liver Cancer     11/24/2014
Milestone Pharmaceuticals Announces Positive Phase 1 Data For MSP-2017; Supports Advancement Into Phase 2 In PSVT Patients     11/24/2014
Synthetic Biologics, Inc. (SYN) Safe-To-Proceed Under IND To Initiate Clinical Trials Of SYN-004 For The Prevention C. Difficile Infection     11/24/2014
Transition Therapeutics Inc. (TTH.TO)' ELND005 Showed No Prolongation Of QT Interval     11/24/2014
The Journal of Clinical Endocrinology & Metabolism Publishes Radius Health's Phase 2 Study Of The Investigational Drug Abaloparatide In Postmenopausal Women With Osteoporosis     11/24/2014
Genmab, Inc. (GEN.CO) Announces Phase 2 Study Of Daratumumab In Smoldering Multiple Myeloma     11/24/2014
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Publication Of REVEAL-1 Trial Results In The British Journal Of Haematology     11/24/2014
Catabasis Pharmaceuticals, Inc. Receives FDA Orphan Drug Designation For CAT-1004 For The Treatment Of Duchenne Muscular Dystrophy     11/24/2014
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Pediatric Schizophrenia     11/24/2014
BioRestorative Therapies, Inc. Schedules Pre-IND Meeting With FDA     11/24/2014
Admedus HPV Vaccine Heads To The Clinic     11/24/2014
Luoxis Announces Presentation Of Multiple Studies Validating Redoxsys As A Rapid And Non-Invasive Means Of Assessing Oxidative Stress     11/24/2014
Cesca Therapeutics Announces Filing Of U.S. Pivotal IDE Application For No-Option Critical Limb Ischemia ("CLI")     11/24/2014
NPS Pharmaceuticals, Inc. (NPSP) Release: Teduglutide Granted Orphan Drug Designation In Japan     11/24/2014
Medical University of Vienna Release: Possible Cause Discovered For Failure Of Targeted Liver Cancer Therapies     11/24/2014
New York University School of Medicine Release: Epilepsy Seizures Drop 50% In Cannabidiol Study     11/24/2014
St. Jude Children's Research Hospital Release: Survivors Of Childhood Eye Cancer Experience Normal Cognitive Functioning As Adults     11/24/2014
Omnicare, Inc. (OCR) And McKesson Corporation Expand Distribution Agreement     11/24/2014
Sevion Therapeutics Announces Chimerasome Research Agreement     11/24/2014
Boston Therapeutics, Inc. and Advance Pharmaceutical Expand Agreement To Market Sugardown® In 12 Additional Countries In Asia     11/24/2014
MRC Technology And Yabao Pharmaceuticals Announce Exclusive Partnership In China To Develop Novel Therapeutics For Parkinson’s Disease     11/24/2014
Chembio Diagnostics, Inc. (CEMI.OB) Signs Agreement With CDC Contractor To Develop A Multiplex Point-Of-Care Test For Influenza Immunity     11/24/2014
Karmanos Cancer Institute's Hayley Thompson, Ph.D., Awarded $1.8 Million Grant To Improve Access To Cancer Survivor Resources     11/24/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Docetaxel Injection USP     11/24/2014
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03%     11/24/2014
Forward Pharma (FWP) Receives Issue Notification For Erosion Matrix Patent In The U.S.     11/24/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fifth U.S. Patent Protecting Trokendi XR(R)     11/24/2014
Catalyst Pharmaceuticals (CPRX) Announces Notice Of Allowance Of U.S. Patent Application For The Reduction Or Elimination Of Visual Field Defects By Treating Patients With CPP-115     11/24/2014
ChromaDex, Inc. Announces Two Patent Issuances For Novel Ingredient, Pterostilbene     11/24/2014
Perrigo Company plc Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary, Perrigo Finance plc     11/24/2014
Perrigo Company plc Announces Underwriters' Full Exercise Of Option To Purchase Ordinary Shares In Connection With The Equity Offering     11/24/2014
OnCore Biopharma Announces Confidential Submission Of Draft Registration Statement For Initial Public Offering     11/24/2014
Neovacs SA Granted 1 Million Euro In Research Tax Credit     11/24/2014
PlasmaTech Biopharmaceuticals, Inc. Announces Stock Ticker Symbol Change To PTBI     11/24/2014
Proteon Therapeutics, Inc. (PRTO) Announces The Closing Of Initial Public Offering And The Underwriters' Option To Purchase Additional Shares     11/24/2014
Medgenics, Inc. Announces Public Offering of Common Stock     11/24/2014
CollabRx, Inc. Announces Receipt Of NASDAQ Notice Of Bid Price Deficiency     11/24/2014
Amicus Therapeutics, Inc. (FOLD) Announces Closing Of Underwritten Offering Of Common Stock And Full Exercise Of Over-Allotment Option     11/24/2014
White Paper Describes NovaBay Pharmaceuticals, Inc. (NBY)’s Non-Antibiotic Anti-Infective Portfolio     11/24/2014
Ora-CAC® Model Provided Platform For Recent Positive Phase 2 Data For Ocular Therapeutix, Inc. (OCUL)’s OTX-DP In Allergic Conjunctivitis     11/24/2014
Marrone Bio Innovations, Inc Receives NASDAQ Notice Regarding Late Form 10-Q Filing     11/24/2014
Regeneus (RGS.AX) Concludes Strategic Review And Sets Platform For Next Phase Of Development     11/24/2014
Nanjing Frontier Biotech In-licenses Novel Patch Pain Product     11/24/2014
Beximco Pharmaceuticals Becomes First Bangladeshi Company To Receive GMP Approval From Health Canada     11/24/2014
BioSTL Release: Israeli Agtech Company Chooses St. Louis As U.S. Headquarters     11/24/2014
Ipsen Biopharmaceuticals, Inc. Announces IPSEN CARES™, An Enhanced Patient Support Program     11/24/2014
AV Therapeutics Successfully Completes GMP Synthesis Of Its Lead Prostate Cancer Chemotherapeutic Drug, Capridine     11/24/2014
Tekmira (TKMR) Provides Key Highlights Of Analyst And Investor Day In New York     11/24/2014
Conatus Pharmaceuticals Inc. To Present At Two December Investor Conferences     11/24/2014
Nuvilex (NVLX) Announces The Formation Of A Diabetes Consortium For The Development Of Its Treatment For Insulin-Dependent Diabetes     11/24/2014
Medac Pharma, Inc. Brings Motion To Preliminarily Prohibit Antares Pharma, Inc. (ATRS) Sales Of Otrexup To New Patients     11/24/2014
Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation From European Medicines Agency     11/24/2014
FDA Grants QIDP Designation To Bayer AG (BAYZF)'s Amikacin Inhale And Ciprofloxacin Dry Powder For Inhalation     11/24/2014
GW Pharmaceuticals To Report Q4, Year-End 2014 Financial Results And Host Conference Call On 2 December, 2014     11/24/2014
Enanta Pharmaceuticals, Inc. Reports Financial Results For its Fiscal Fourth Quarter And Year Ended September 30, 2014     11/24/2014
ProQR Therapeutics B.V. (PRQR) Announces Results For The Third Quarter Of 2014     11/24/2014
Agilis Biotherapeutics Names Former Shire Executive Dr. Gregory Robinson As Chief Scientific Officer     11/24/2014
Bone Therapeutics Appoints Dr. Guy Heynen As Chief Clinical And Regulatory Officer     11/24/2014
Arthritis Foundation Selects Michael Ortman As Board Chair     11/24/2014
Matinas BioPharma Appoints Leading Clinical Lipid Specialist And Metabolism Researcher, Kevin C. Maki, Ph.D., To Scientific Advisory Board     11/24/2014
The SEED Partners Appoints Doug Kohrs To Chair Advisory Board     11/24/2014
Verona Pharma (VRP.L) Release: Appointment Of Dr. David Ebsworth As Non-Executive Chairman Of The Board Of Directors     11/24/2014
Inovio Pharmaceuticals (INO) To Ring Opening Bell Nov 25th On The Nasdaq Stock Market     11/24/2014
The Government Of Canada And True Patriot Love Foundation Support Initiatives To Improve The Health Of Health Canada's Armed Forces Personnel, Veterans And Their Families     11/24/2014
Inovio Pharmaceuticals (INO) (Nasdaq: INO) To Ring The Nasdaq Stock Market Opening Bell     11/24/2014
Aerogen Awarded As Exporter Of The Year     11/24/2014
Medidata Solutions, Inc. To Host Financial Analyst Day In New York City On December 8     11/24/2014
VolitionRX To Present Positive Data From Pilot Lung Cancer Study At Biowin Day 2014     11/24/2014
Emmaus Life Sciences To Present Phase 3 Sickle Cell Disease Trial Data At 56th American Society of Hematology Annual Meeting     11/24/2014
Acceleron Pharma To Present At Upcoming Investor Conferences In December     11/24/2014
Simulations Plus (SLP) To Attend The Benchmark Company, LLC’s Micro Cap Discovery Conference In Chicago On December 11     11/24/2014
Infinity Pharmaceuticals Inc. (INFI) To Present At Deutsche Bank (DB) Securities 2014 BioFEST Conference     11/24/2014
Sprout Pharmaceuticals Presents Phase 1 Clinical Trial Data Showing Treatment With Flibanserin Results In No Next-Day Driving Impairment     11/24/2014
Study On Efficacy And Sedation-Related Safety Of Flibanserin In Premenopausal Women Released Today At Sexual Medicine Society Of North America Meeting     11/24/2014
Sarepta Therapeutics (SRPT) To Present Company Overview At Upcoming Conferences     11/24/2014
Cellectis (ALCLS) Announces Upcoming Presentations At The 56th Annual Meeting Of American Society of Hematology     11/24/2014
Relmada Therapeutics To Present At LD MICRO Conference     11/24/2014
Emergent BioSolutions (EBS) To Webcast Presentation At 25th Annual Oppenheimer Healthcare Conference     11/24/2014
Aegerion Pharmaceuticals, Inc. (AEGR) To Present At The Deutsche Bank (DB) BioFest Conference     11/24/2014
Alcobra (ADHD) To Present At Investor Conferences In December     11/24/2014
Gateway Analytical To Present On The Characterization Of Particulate In Inhalable Drug Products At The Drug Delivery To Lungs Conference     11/24/2014
Veracyte, Inc. (VCYT) To Present At The Piper Jaffray 26th Annual Healthcare Conference     11/24/2014
Anthera Pharmaceuticals, Inc. (ANTH) To Present At Annual Piper Jaffray Healthcare Conference     11/24/2014
Aerie Pharmaceuticals, Inc. (AERI) To Present At Piper Jaffray 26th Annual Healthcare Conference     11/24/2014
Pernix Therapeutics, Inc. (PTX) To Present At The 26th Annual Piper Jaffray Healthcare Conference     11/24/2014
Arena Pharmaceuticals, Inc. (ARNA) To Present At Piper Jaffray 26th Annual Healthcare Conference     11/24/2014
Fluidigm Corporation To Present At Piper Jaffray 26th Annual Healthcare Conference     11/24/2014
XOMA Corporation (XOMA) To Present At The Piper Jaffray Healthcare Conference     11/24/2014
Versartis, Inc. (VSAR) To Present At The 26th Annual Piper Jaffray Health Care Conference     11/24/2014
Celator Pharmaceuticals, Inc. To Present Data At The 56th American Society of Hematology Annual Meeting     11/24/2014
Arno Therapeutics To Present At LD Micro Conference 2014     11/24/2014
Amarantus To Present At The LD Micro Main Event VII Investor Conference On December 2, 2014     11/24/2014
VBI To Present At The LD Micro Conference     11/24/2014

Career Tips
Ardea Biosciences, Inc. HR VP Shares A Fool-Proof Guide To Joining A Startup     11/20/2014
3 Signs Your Resume Isn't Working     11/20/2014
3 Deadly Mistakes Made In Job Interviews     11/20/2014
4 Essentials Of A Good Cover Letter     11/20/2014
Sanofi (SAN.PA) And Incyte Corporation (INCY) Execs Exclusive: Future Hiring Trends And What They're Looking For In New Hires     11/7/2014
4 Common Mistakes That Sabotage Your Resume     11/6/2014
3 Tips To Capture The Hiring Manager's Interest In Seconds     11/6/2014
10 Shocking Job Search Blunders     11/6/2014
Eli Lilly (LLY) And Luminex (LMNX) Exclusive: Straight Talk From Career Experts On How To Get Hired     10/27/2014
Get The Inside Track: Hiring Tips From An Eli Lilly (LLY) HR Exec     10/23/2014
5 Bad Interview Answers To Avoid     10/23/2014
What Separates Good Resumes From Bad Resumes?     10/23/2014
6 Out-Of-The-Box Job Search Ideas That Worked     10/23/2014
Is Pursuing A Ph.D. Worth It? 7,200 UC Ph.D. Alumni Respond     10/17/2014
Biotech’s Biggest Hirers Of The Last 5 Years     10/13/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do

Press Release Submissions
Post your news